Cargando…

HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer

OBJECTIVE: In this study, we evaluate the frequency of HER-2 and HER-3 expression in liver metastases from patients with colorectal cancer (CRLM). We analyzed the potential of HER-2 and HER-3 as therapeutic targets and evaluated their prognostic value. PATIENTS AND METHODS: Overall 208 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Styczen, Hanna, Nagelmeier, Iris, Beissbarth, Tim, Nietert, Manuel, Homayounfar, Kia, Sprenger, Thilo, Boczek, Ute, Stanek, Kathrin, Kitz, Julia, Wolff, Hendrik A., Ghadimi, B. Michael, Middel, Peter, Liersch, Torsten, Rüschoff, Josef, Conradi, Lena-Christin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4558136/ https://www.ncbi.nlm.nih.gov/pubmed/25915155

Ejemplares similares

The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer
por: Rühlmann, Felix, et al.
Publicado: (2017)

Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
por: Conradi, Lena-Christin, et al.
Publicado: (2019)

Thymidylate Synthase as a Prognostic Biomarker for Locally Advanced Rectal Cancer after multimodal Treatment
por: Conradi, Lena-Christin, et al.
Publicado: (2011)

Preoperative Chemoradiotherapy Does Not Necessarily Reduce Lymph Node Retrieval in Rectal Cancer Specimens—Results from a Prospective Evaluation with Extensive Pathological Work-up
por: Sprenger, Thilo, et al.
Publicado: (2009)

The utilization of multidisciplinary tumor boards (MDT) in clinical routine: results of a health care research study focusing on patients with metastasized colorectal cancer
por: Lowes, Markus, et al.
Publicado: (2017)

Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies
por: Jo, Peter, et al.
Publicado: (2016)

Oxaliplatin-Induced Leukocytoclastic Vasculitis under Adjuvant Chemotherapy for Colorectal Cancer: Two Cases of a Rare Adverse Event
por: Quack, Henriette, et al.
Publicado: (2013)

β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases
por: Bleckmann, Annalen, et al.
Publicado: (2016)

Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment
por: Homayounfar, K., et al.
Publicado: (2012)

Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status
por: Rüschoff, Josef, et al.
Publicado: (2022)

STED Super-Resolution Microscopy of Clinical Paraffin-Embedded Human Rectal Cancer Tissue
por: Ilgen, Peter, et al.
Publicado: (2014)

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing
por: Rüschoff, Josef, et al.
Publicado: (2010)

Ultrasonic scalpel causes greater depth of soft tissue necrosis compared to monopolar electrocautery at standard power level settings in a pig model
por: Homayounfar, Kia, et al.
Publicado: (2012)

Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: Do we have indications for individual risk stratification?
por: Sprenger, Thilo, et al.
Publicado: (2010)

Metastatic recurrence after complete resection of colorectal liver metastases: impact of surgery and chemotherapy on survival
por: Homayounfar, K., et al.
Publicado: (2013)

Multimodal treatment options for bilobar colorectal liver metastases
por: Homayounfar, Kia, et al.
Publicado: (2010)

Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer
por: Scheel, Andreas H., et al.
Publicado: (2018)

FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis
por: Fromme, Julia Elisabeth, et al.
Publicado: (2018)

mRNA Profiling Reveals Determinants of Trastuzumab Efficiency in HER2-Positive Breast Cancer
por: von der Heyde, Silvia, et al.
Publicado: (2015)

Prognostic value of the micronucleus assay for clinical endpoints in neoadjuvant radiochemotherapy for rectal cancer
por: Dröge, Leif Hendrik, et al.
Publicado: (2021)

Cure Is Possible: Extensively Metastatic HER2-Positive Gastric Carcinoma with 5 years of Complete Remission after Therapy with the FLOT Regimen and Trastuzumab
por: Schade, Sebastian, et al.
Publicado: (2022)

High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome
por: Menck, Kerstin, et al.
Publicado: (2022)

Heterogeneity of KRAS Mutation Status in Rectal Cancer
por: Jo, Peter, et al.
Publicado: (2016)

HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer
por: Schulz, R, et al.
Publicado: (2014)

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
por: Van Cutsem, Eric, et al.
Publicado: (2014)

HER kinase inhibition in patients with HER2- and HER3-mutant cancers
por: Hyman, David M., et al.
Publicado: (2018)

Neue Therapiemöglichkeiten beim metastasierten HER2-low-Mammakarzinom: Konsequenzen für die histopathologische Diagnostik
por: Denkert, Carsten, et al.
Publicado: (2022)

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients
por: Sassen, Andrea, et al.
Publicado: (2008)

Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer
por: Azizian, Azadeh, et al.
Publicado: (2016)

The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
por: Majumder, Avisek, et al.
Publicado: (2021)

Comparing Apparent Diffusion Coefficient and FNCLCC Grading to Improve Pretreatment Grading of Soft Tissue Sarcoma—A Translational Feasibility Study on Fusion Imaging
por: Hettler, Madelaine, et al.
Publicado: (2022)

Model-Based Analysis of HER Activation in Cells Co-Expressing EGFR, HER2 and HER3
por: Shankaran, Harish, et al.
Publicado: (2013)

Pyloric gland adenoma of the cystic duct with malignant transformation: report of a case with a review of the literature
por: Schaefer, Inga-Marie, et al.
Publicado: (2012)

Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study
por: van de Vijver, Marc, et al.
Publicado: (2007)

The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients
por: Memon, A A, et al.
Publicado: (2006)

“Everything for Her!”
por: Andrijević Matovac, Vesna
Publicado: (2011)

In her family /
por: Metheny, Pat
Publicado: (1987)

ADVICE TO THE EXPECTANT MOTHER ON THE CARE OF HER HEALTH AND THAT OF HER CHILD
Publicado: (1947)

HER-3 expression in HER-2-amplified breast carcinoma
por: Czopek, Jacek, et al.
Publicado: (2013)

Advice to the Expectant Mother on the Care of Her Health and That of Her Child
Publicado: (1947)

Cannot write session to /tmp/vufind_sessions/sess_p92lfssgcbqn1404kir7r7a35a